◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Lonza Group AG (LONN) Financial History

Name: Lonza Group AG (LONN) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Diagnostics & Research · DATA UPDATED 2026-08-16

Lonza Group AG (LONN) operates in the Diagnostics & Research industry and is headquartered in Basel, Switzerland with about 20,141 employees. Its market capitalization is roughly CHF 39 billion. In the fiscal year ended 2025-12-31, LONN reported CHF 6.5B in revenue and (CHF 275M) in net income.

Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally.

Interactive charts & full statements →

LONN Revenue & Earnings History — Annual Income Statement

Income statement	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Total Revenue	CHF 6.5B	CHF 5.5B	CHF 6.7B	CHF 6.2B	—
Gross Profit	CHF 2.3B	CHF 1.8B	CHF 1.9B	CHF 2.4B	—
Operating Income (EBIT)	CHF 1.4B	CHF 879M	CHF 873M	CHF 1.4B	—
Net Income	(CHF 275M)	CHF 636M	CHF 654M	CHF 1.2B	—

CHF; CHFM / CHFB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

LONN Free Cash Flow History

Cash flow	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Dividends Paid	(CHF 282M)	(CHF 288M)	(CHF 263M)	(CHF 228M)	—

CHF; CHFM / CHFB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

LONN Balance Sheet History

Balance sheet	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Total Assets	CHF 17.9B	CHF 19.7B	CHF 16.8B	CHF 17.4B	—
Total Liabilities	CHF 9.9B	CHF 10.3B	CHF 7.3B	CHF 6.7B	—

CHF; CHFM / CHFB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive LONN viewer.

Other Companies in Diagnostics & Research

4544 · H.U. Group Holdings, Inc. — $194 billion
4694 · BML, Inc. — $134 billion
2268 · WuXi XDC Cayman Inc. — $81 billion
2395 · Shin Nippon Biomedical Laboratories, Ltd. — $62 billion
3347 · Hangzhou Tigermed Consulting Co., Ltd — $35 billion
4671 · FALCO HOLDINGS Co., Ltd. — $27 billion
6127 · Joinn Laboratories(China)Co.,Ltd. — $21 billion
ERF · Eurofins Scientific SE — $12 billion

← LONA All “L” companies LOOP →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.